Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.7850
-0.0250 (-3.09%)
Sep 10, 2026, 4:10 PM AEST
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of 374.33 million as of September 10, 2026. Its market cap has increased by 616.03% in one year.
Market Cap
374.33M
Enterprise Value
364.02M
Revenue
12.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.79
ChartMarket Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 50.00M to 374.33M, an increase of 648.65%. That is a compound annual growth rate of 8.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 374.33M | 148.62% |
| Dec 31, 2025 | 150.56M | 227.36% |
| Dec 31, 2024 | 45.99M | -34.30% |
| Dec 29, 2023 | 70.01M | -68.87% |
| Dec 30, 2022 | 224.87M | -58.74% |
| Dec 31, 2021 | 544.95M | -14.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 846.89M |
| Racura Oncology | 417.63M |
| Clinuvel Pharmaceuticals | 411.49M |
| Tetratherix | 377.88M |
| BLS Pharmaceuticals | 253.33M |
| Actinogen Medical | 219.44M |
| Orthocell | 198.80M |
| Nyrada | 182.85M |